annual EBITDA:
-$82.22M-$46.15M(-127.95%)Summary
- As of today (September 9, 2025), RAPP annual EBITDA is -$82.22 million, with the most recent change of -$46.15 million (-127.95%) on December 31, 2024.
- During the last 3 years, RAPP annual EBITDA has fallen by -$71.86 million (-694.20%).
- RAPP annual EBITDA is now -694.20% below its all-time high of -$10.35 million, reached on December 31, 2022.
Performance
RAPP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$29.24M-$2.38M(-8.86%)Summary
- As of today (September 9, 2025), RAPP quarterly EBITDA is -$29.24 million, with the most recent change of -$2.38 million (-8.86%) on June 1, 2025.
- Over the past year, RAPP quarterly EBITDA has dropped by -$8.65 million (-42.02%).
- RAPP quarterly EBITDA is now -464.99% below its all-time high of -$5.18 million, reached on March 31, 2023.
Performance
RAPP quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$100.79M-$8.65M(-9.39%)Summary
- As of today (September 9, 2025), RAPP TTM EBITDA is -$100.79 million, with the most recent change of -$8.65 million (-9.39%) on June 1, 2025.
- Over the past year, RAPP TTM EBITDA has dropped by -$48.52 million (-92.81%).
- RAPP TTM EBITDA is now -1847.26% below its all-time high of -$5.18 million, reached on March 31, 2023.
Performance
RAPP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RAPP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -128.0% | -42.0% | -92.8% |
| 3 y3 years | -694.2% | -465.0% | -1847.3% |
| 5 y5 years | -694.2% | -465.0% | -1847.3% |
RAPP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -694.2% | at low | -465.0% | at low | -1847.3% | at low |
| 5 y | 5-year | -694.2% | at low | -465.0% | at low | -1847.3% | at low |
| alltime | all time | -694.2% | at low | -465.0% | at low | -1847.3% | at low |
RAPP EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$29.24M(+8.9%) | -$100.79M(+9.4%) |
| Mar 2025 | - | -$26.86M(+15.5%) | -$92.14M(+12.1%) |
| Dec 2024 | -$82.22M | -$23.26M(+8.6%) | -$82.22M(+11.6%) |
| Sep 2024 | - | -$21.42M(+4.0%) | -$73.70M(+41.0%) |
| Jun 2024 | - | -$20.59M(+21.5%) | -$52.27M(+36.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$16.94M(+14.9%) | -$38.29M(+44.4%) |
| Dec 2023 | -$36.07M(+248.4%) | -$14.74M(+123.0%) | -$26.53M(+125.1%) |
| Jun 2023 | - | -$6.61M(+27.7%) | -$11.79M(+127.7%) |
| Mar 2023 | - | -$5.18M | -$5.18M |
| Dec 2022 | -$10.35M | - | - |
FAQ
- What is Rapport Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Rapport Therapeutics, Inc.?
- What is Rapport Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Rapport Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Rapport Therapeutics, Inc.?
- What is Rapport Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Rapport Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Rapport Therapeutics, Inc.?
- What is Rapport Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Rapport Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of RAPP is -$82.22M
What is the all time high annual EBITDA for Rapport Therapeutics, Inc.?
Rapport Therapeutics, Inc. all-time high annual EBITDA is -$10.35M
What is Rapport Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, RAPP annual EBITDA has changed by -$46.15M (-127.95%)
What is Rapport Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of RAPP is -$29.24M
What is the all time high quarterly EBITDA for Rapport Therapeutics, Inc.?
Rapport Therapeutics, Inc. all-time high quarterly EBITDA is -$5.18M
What is Rapport Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, RAPP quarterly EBITDA has changed by -$8.65M (-42.02%)
What is Rapport Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of RAPP is -$100.79M
What is the all time high TTM EBITDA for Rapport Therapeutics, Inc.?
Rapport Therapeutics, Inc. all-time high TTM EBITDA is -$5.18M
What is Rapport Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, RAPP TTM EBITDA has changed by -$48.52M (-92.81%)